Introduction – Company Background

GuangXin Industrial Co., Ltd. is a specialized manufacturer dedicated to the development and production of high-quality insoles.

With a strong foundation in material science and footwear ergonomics, we serve as a trusted partner for global brands seeking reliable insole solutions that combine comfort, functionality, and design.

With years of experience in insole production and OEM/ODM services, GuangXin has successfully supported a wide range of clients across various industries—including sportswear, health & wellness, orthopedic care, and daily footwear.

From initial prototyping to mass production, we provide comprehensive support tailored to each client’s market and application needs.

At GuangXin, we are committed to quality, innovation, and sustainable development. Every insole we produce reflects our dedication to precision craftsmanship, forward-thinking design, and ESG-driven practices.

By integrating eco-friendly materials, clean production processes, and responsible sourcing, we help our partners meet both market demand and environmental goals.

Core Strengths in Insole Manufacturing

At GuangXin Industrial, our core strength lies in our deep expertise and versatility in insole and pillow manufacturing. We specialize in working with a wide range of materials, including PU (polyurethane), natural latex, and advanced graphene composites, to develop insoles and pillows that meet diverse performance, comfort, and health-support needs.

Whether it's cushioning, support, breathability, or antibacterial function, we tailor material selection to the exact requirements of each project-whether for foot wellness or ergonomic sleep products.

We provide end-to-end manufacturing capabilities under one roof—covering every stage from material sourcing and foaming, to precision molding, lamination, cutting, sewing, and strict quality control. This full-process control not only ensures product consistency and durability, but also allows for faster lead times and better customization flexibility.

With our flexible production capacity, we accommodate both small batch custom orders and high-volume mass production with equal efficiency. Whether you're a startup launching your first insole or pillow line, or a global brand scaling up to meet market demand, GuangXin is equipped to deliver reliable OEM/ODM solutions that grow with your business.

Customization & OEM/ODM Flexibility

GuangXin offers exceptional flexibility in customization and OEM/ODM services, empowering our partners to create insole products that truly align with their brand identity and target market. We develop insoles tailored to specific foot shapes, end-user needs, and regional market preferences, ensuring optimal fit and functionality.

Our team supports comprehensive branding solutions, including logo printing, custom packaging, and product integration support for marketing campaigns. Whether you're launching a new product line or upgrading an existing one, we help your vision come to life with attention to detail and consistent brand presentation.

With fast prototyping services and efficient lead times, GuangXin helps reduce your time-to-market and respond quickly to evolving trends or seasonal demands. From concept to final production, we offer agile support that keeps you ahead of the competition.

Quality Assurance & Certifications

Quality is at the heart of everything we do. GuangXin implements a rigorous quality control system at every stage of production—ensuring that each insole meets the highest standards of consistency, comfort, and durability.

We provide a variety of in-house and third-party testing options, including antibacterial performance, odor control, durability testing, and eco-safety verification, to meet the specific needs of our clients and markets.

Our products are fully compliant with international safety and environmental standards, such as REACH, RoHS, and other applicable export regulations. This ensures seamless entry into global markets while supporting your ESG and product safety commitments.

ESG-Oriented Sustainable Production

At GuangXin Industrial, we are committed to integrating ESG (Environmental, Social, and Governance) values into every step of our manufacturing process. We actively pursue eco-conscious practices by utilizing eco-friendly materials and adopting low-carbon production methods to reduce environmental impact.

To support circular economy goals, we offer recycled and upcycled material options, including innovative applications such as recycled glass and repurposed LCD panel glass. These materials are processed using advanced techniques to retain performance while reducing waste—contributing to a more sustainable supply chain.

We also work closely with our partners to support their ESG compliance and sustainability reporting needs, providing documentation, traceability, and material data upon request. Whether you're aiming to meet corporate sustainability targets or align with global green regulations, GuangXin is your trusted manufacturing ally in building a better, greener future.

Let’s Build Your Next Insole Success Together

Looking for a reliable insole manufacturing partner that understands customization, quality, and flexibility? GuangXin Industrial Co., Ltd. specializes in high-performance insole production, offering tailored solutions for brands across the globe. Whether you're launching a new insole collection or expanding your existing product line, we provide OEM/ODM services built around your unique design and performance goals.

From small-batch custom orders to full-scale mass production, our flexible insole manufacturing capabilities adapt to your business needs. With expertise in PU, latex, and graphene insole materials, we turn ideas into functional, comfortable, and market-ready insoles that deliver value.

Contact us today to discuss your next insole project. Let GuangXin help you create custom insoles that stand out, perform better, and reflect your brand’s commitment to comfort, quality, and sustainability.

🔗 Learn more or get in touch:
🌐 Website: https://www.deryou-tw.com/
📧 Email: shela.a9119@msa.hinet.net
📘 Facebook: facebook.com/deryou.tw
📷 Instagram: instagram.com/deryou.tw

Vietnam custom product OEM/ODM services

Are you looking for a trusted and experienced manufacturing partner that can bring your comfort-focused product ideas to life? GuangXin Industrial Co., Ltd. is your ideal OEM/ODM supplier, specializing in insole production, pillow manufacturing, and advanced graphene product design.

With decades of experience in insole OEM/ODM, we provide full-service manufacturing—from PU and latex to cutting-edge graphene-infused insoles—customized to meet your performance, support, and breathability requirements. Our production process is vertically integrated, covering everything from material sourcing and foaming to molding, cutting, and strict quality control.Taiwan ODM expert factory for comfort product development

Beyond insoles, GuangXin also offers pillow OEM/ODM services with a focus on ergonomic comfort and functional innovation. Whether you need memory foam, latex, or smart material integration for neck and sleep support, we deliver tailor-made solutions that reflect your brand’s values.

We are especially proud to lead the way in ESG-driven insole development. Through the use of recycled materials—such as repurposed LCD glass—and low-carbon production processes, we help our partners meet sustainability goals without compromising product quality. Our ESG insole solutions are designed not only for comfort but also for compliance with global environmental standards.High-performance insole OEM Thailand

At GuangXin, we don’t just manufacture products—we create long-term value for your brand. Whether you're developing your first product line or scaling up globally, our flexible production capabilities and collaborative approach will help you go further, faster.Taiwan OEM insole and pillow manufacturing factory

📩 Contact us today to learn how our insole OEM, pillow ODM, and graphene product design services can elevate your product offering—while aligning with the sustainability expectations of modern consumers.Innovative insole ODM solutions in Thailand

A groundbreaking study reveals the mechanisms behind sensory evolution in fruit flies, showing how genetic and cellular variations enable them to adapt their senses to different environments. The research uncovers the diversity in olfactory perception and the presence of sex-specific differences, offering insights into the evolution of sensory systems across species. Credit: SciTechDaily.com New research uncovers the genetic basis of sensory adaptation in fruit flies, revealing diverse olfactory experiences and sex-specific differences in scent detection. A new study published today (February 5) in Nature Communications unveils the hidden world of sensory evolution in fruit flies. By delving into the genes and cells behind their delicate noses and tongues, researchers have discovered surprising secrets about how these tiny insects adapt their senses to different environments. “Imagine a world where a ripe peach tastes and smells like tangy vinegar to one fly, but like a burst of summer to another,” explains principal author of the study Dr. Roman Arguello, a Lecturer in Genetics, Genomics and Fundamental Cell Biology at Queen Mary University of London. “Our study shows that this is not just possible, but it’s actually quite common.” Genetic Insights Into Olfaction The research team analyzed the gene expression patterns in five key scent-detecting tissues across six different Drosophila species. This comprehensive approach allowed them to delve deeper than ever before into the molecular underpinnings of smell. One surprising discovery was the prevalence of “stabilizing selection,” a force that keeps most genes expressed at the same levels across generations. However, within this sea of stability, the researchers found thousands of genes that had undergone significant changes in expression, shaping the unique olfactory landscapes of different fly species. Chemosensory tissue transcriptome evolution. Credit: Gwénaëlle Bontonou et. al./Nature Communications Diversity and Sex Differences in Sensory Perception “It’s like finding hidden islands of diversity within a vast ocean of uniformity,” says Dr. Arguello. “These changes in gene expression tell us about the evolution of new smells, new sensitivities, and even new ways of using scent to navigate the world.” The study also reveals intriguing differences between the sexes. In fruit flies, as in many other animals, males and females often experience the world through different olfactory lenses. The researchers identified a surprising excess of male-biased gene expression in the front legs of D. melanogaster, suggesting that these limbs play a crucial role in male-specific scent detection. “These findings open up exciting new avenues for understanding how sex differences evolve and how they impact animal behavior,” says Dr. Arguello. The study’s implications extend beyond the fascinating world of flies. It provides valuable insights into the general principles of how sensory systems evolve, offering clues to understanding how other animals, including humans, perceive their chemical environments. Reference: “Evolution of chemosensory tissues and cells across ecologically diverse Drosophilids” by Gwénaëlle Bontonou, Bastien Saint-Leandre, Tane Kafle, Tess Baticle, Afrah Hassan, Juan Antonio Sánchez-Alcañiz and J. Roman Arguello, 5 February 2024, Nature Communications. DOI: 10.1038/s41467-023-44558-4

3d illustration of a cross-section of an Ebola pathogen. LJI team uncovers how one odd antibody does some heavy lifting. Researchers at La Jolla Institute for Immunology (LJI) are designing better therapies for treating Ebola virus and its deadly relatives. Despite the name confusion, Ebola virus is just one species in the Ebolavirus genus. There’s the Ebola virus (two words) species, and then there’s Sudan ebolavirus, Bundibugyo ebolavirus, Reston ebolavirus, Taï Forest ebolavirus and Bombali ebolavirus. These viruses are all dangerous, but scientists so far have only developed therapies against the more well-known Ebola virus. To save lives, doctors need broad-spectrum therapies that neutralize as many Ebolavirus species as possible. LJI President and CEO Erica Ollmann Saphire, Ph.D. and her partner Rafi Ahmed, Ph.D. at Emory University are on the hunt for human antibodies that target vulnerable sites across Ebolavirus species. The team’s latest study, published in Cell, shows that two clever human antibodies can target two ebolavirus species at once: Ebola virus and Sudan virus. These two species are responsible for the biggest, deadliest outbreaks. The new report suggests researchers could combine these two potent antibodies to make a powerful antiviral therapy. “Finding antibodies with this breadth is important because we don’t know which virus in the genus of ebolaviruses is going to break out next,” says Saphire. In addition to Saphire and Ahmed, the new research was co-led by Gabriella Worwa, D.V.M., Ph.D., of the National Institute for Allergy and Infectious Diseases. The two antibodies in this study came from survivors of Ebola virus infection who donated samples to study co-leaders at Emory University, and the Ebola monoclonal antibodies were generated by Carl Davis, Ph.D., at Emory University. What Makes These Antibodies Special? To learn how these antibodies neutralize ebolaviruses, LJI Postdoctoral Fellows Xiaoying Yu, Ph.D., and Jake Milligan, Ph.D., spearheaded the use of an imaging technique called cryo-electron microscopy. This technique gave them a clear view of how the two antibodies, called 1C3 and 1C11, bind to vulnerable sites on a key ebolavirus protein, called the glycoprotein. The team was surprised to see that 1C3 attacked the glycoprotein in an unexpected way. Instead of sticking to one site on the glycoprotein, like a key in a lock, the 1C3 lodged itself in an asymmetrical configuration, which let it block three glycoprotein sites at once. “This antibody might punch above its weight,” says Saphire. “The antibody is able to block three sites on the virus at the same time using different loops and structures to anchor into each one. That is remarkable.” Meanwhile, the paired antibody 1C11 binds to the fusion machinery the virus would normally use to enter and infect host cells. As Saphire explains, because the fusion machinery has such a critical job, it looks very similar between Sudan virus and Ebola virus. “This is a site of very broad recognition and resistance to any antibody escape,” she says. “That’s how this antibody gets its breadth.” There are still four more Ebolavirus species to address, but Ebola virus and Sudan virus have caused the largest and most lethal outbreaks. There’s one more reason these two antibodies make a dream team: They aren’t easily distracted. While there are antibody therapies against Ebola virus, some antibodies in these therapies don’t actually neutralize the virus. Instead, the antibodies home in on a decoy protein, called soluble glycoprotein, that the virus makes. Fortunately, 1C3 and 1C11 ignore the decoy and go straight for the virus’s actual surface glycoprotein structure. This means the researchers could use fewer antibodies to effectively target Ebola virus and Sudan virus. “If 80-90% of what’s there is some kind of smokescreen, having antibodies that can target the vulnerable spot is valuable,” Saphire says. The two antibodies had the right stuff—and they performed very well outside the lab. Study collaborators found that combining 1C3 and 1C11 in an antibody therapy could protect against Ebola virus and Sudan virus disease in non-human primates, reversing severe symptoms. “These are both very potent antibodies,” says Yu. What Does This Mean for Patients? The fighting power of 1C3 and 1C11 could mean more lives saved when every second matters. The broad-spectrum effects of the two antibodies makes them a promising therapy for situations when doctors don’t have time to figure out which Ebolavirus species is responsible. Even better, these antibodies may be effective even when given late in the course of the disease. This late treatment would be extremely valuable because many patients with either Ebola virus or Sudan virus have already progressed far into infection when they are diagnosed. “The first symptoms of Ebola virus tend to be a fever and a headache, which can look like a lot of different diseases,” Saphire says. “An antibody that can be used later in the course of disease is a lot more useful.” Going forward, the team is trying to figure out how much lower the dosage could be. In the non-human primate trial, even the lowest dose provided 100 percent protection. Yu says a lower dose may be just as effective. This is an important question to answer because lower doses would make the therapy much cheaper to produce. So for many reasons, a better antibody cocktail means hope for patients. Reference: “Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses” by Jacob C. Milligan, Carl W. Davis, Xiaoying Yu, Philipp A. Ilinykh, Kai Huang, Peter J. Halfmann, Robert W. Cross, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Chakravarthy Chennareddy, Arthur J. Goff, Ashley E. Piper, Sean Hui, Kelly C.L. Shaffer, Tierra Buck, Megan L. Heinrich, Luis M. Branco, Ian Crozier, Michael R. Holbrook, Jens H. Kuhn, Yoshihiro Kawaoka, Pamela J. Glass, Alexander Bukreyev, Thomas W. Geisbert, Gabriella Worwa, Rafi Ahmed and Erica Ollmann Saphire, 17 March 2022, Cell. DOI: 10.1016/j.cell.2022.02.023 Additional authors of the study, “Asymmetric and non-stoichiometric glycoprotein recognition by two distinct antibodies results in broad protection against ebolaviruses,” include co-first authors Jacob C. Milligan and Carl W. Davis, Philipp A. Ilinykh, Kai Huang, Peter Halfmann, Robert W. Cross, Viktoriya Borisevich, Krystle N. Agans, Joan B. Geisbert, Chakravarthy Chennareddy, Arthur J. Goff, Ashley E. Piper, Sean Hui, Kelly Shaffer, Tierra Buck, Megan L. Heinrich, Luis M. Branco, Ian Crozier, Michael R. Holbrook, Jens H. Kuhn, Yoshihiro Kawaoka, Pamela J. Glass, Alexander Bukreyev and Thomas W. Geisbert. This research was supported by the National Institute of Allergy and Infectious Diseases (NIAID) U19 AI142790, Consortium for Immunotherapeutics against Emerging Viral Threats; DARPA contracts W31P4Q-14-1-0010, and U19AI109762. The research was also made possible thanks to private philanthropic support from donors to LJI. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the National Institutes of Health, National Institute of General Medical Sciences (P30GM133894).

A single neuron is shown with 5,600 of the nerve fibers (blue) that connect to it. The synapses that make these connections are in green. Credit: Google Research & Lichtman Lab, Harvard University. Renderings by D. Berger, Harvard Researchers used high-resolution electron microscopy to image a small piece of human brain tissue, generating a 3D map of over 57,000 cells and nearly 150 million synapses. Their findings reveal intricate details about cell types and connections, highlighting the complexity of the brain and advancing the field of connectomics. Researchers generated a high-resolution map of all the cells and connections in a single cubic millimeter of the human brain. The results reveal previously unseen details of brain structure and provide a resource for further studies. Fully understanding how the human brain works requires knowing the relationships between the various cells that make up the brain. This entails visualizing the brain’s structure on the scale of nanometers in order to see the connections between neurons. Imaging Techniques and Research Methodology A team of researchers, led by Dr. Jeff Lichtman at Harvard University and Dr. Viren Jain at Google Research, used electron microscopy (EM) to image a cubic millimeter-sized piece of human brain tissue at high resolution. The tissue was removed from the cerebral cortex of a patient as part of a surgery for epilepsy. The team began by cutting the tissue into more than 5,000 slices, or sections, each of which was then imaged by EM. This yielded about 1.4 petabytes, or 1,400 terabytes, of data. Using these data, the researchers generated a 3D reconstruction of almost every cell in the sample. Results of the NIH-funded study were published in the journal Science. Researchers built a 3D image of nearly every neuron and its connections within a small piece of human brain tissue. This image shows six layers of neurons, colorized according to the size of each cell’s central core. Credit: Google Research & Lichtman Lab, Harvard University. Renderings by D. Berger, Harvard Detailed Findings and Cellular Analysis Analysis of individual cells in the sample revealed a total of more than 57,000 cells. Most of these were either neurons, which send electrical signals, or glia, which provide various support functions to the neurons. Glia outnumbered neurons 2-to-1. The most common glial cells were oligodendrocytes, which provide structural support and electrical insulation to neurons. The one cubic mm sample also contained about 230 mm of blood vessels. The reconstruction revealed structural details not seen before. The researchers analyzed a type of neuron, called triangular cells, that are found in the deepest layer of the cerebral cortex. Many of these adopted one of two orientations, which were mirror images of each other. The significance of this organization remains unknown. Synapses and Connections The team used machine learning to identify synapses—the junctions through which signals pass from one cell to another. They found almost 150 million synapses. Almost all neurons formed only one synapse with a given target cell. But a small fraction formed two or more synapses to the same target. In at least one case, more than 50 synapses connected a single pair of cells. Although rare, connections of seven or more synapses between cells were much more common than expected by chance. This suggests that these strong connections have some functional significance. Connectomics and the Complexity of the Brain The results illustrate just how complex the brain is at the cellular level. They also show the value of connectomics—the science of generating comprehensive maps of connections between brain cells—for understanding brain function. “The word ‘fragment’ is ironic,” Lichtman says. “A terabyte is, for most people, gigantic, yet a fragment of a human brain—just a miniscule, teeny-weeny little bit of human brain—is still thousands of terabytes.” The team has made their dataset available to the public. They have also provided various software tools to help examine the brain map. The hope is that further study of the data, by this team and others, will yield new insight into the workings of the human brain. “This incredible advancement—the ability to capture and process over 1,000 terabytes of data from the brain—wouldn’t have been possible without a study participant’s generous donation and the important partnerships between neuroscientists, computer scientists, and engineers,” says Dr. John Ngai, director of NIH’s BRAIN Initiative. “These collaborations are central in our aim of building a full map of the human brain so we can bring cures closer to the clinic.” For more on this research: Harvard and Google Create Intricately Detailed 1,400 Terabyte 3D Brain Map Nanoscale 3D Mapping Reveals Revolutionary Insights Into Brain Structure Reference: “A petavoxel fragment of human cerebral cortex reconstructed at nanoscale resolution” by Alexander Shapson-Coe, Michał Januszewski, Daniel R. Berger, Art Pope, Yuelong Wu, Tim Blakely, Richard L. Schalek, Peter H. Li, Shuohong Wang, Jeremy Maitin-Shepard, Neha Karlupia, Sven Dorkenwald, Evelina Sjostedt, Laramie Leavitt, Dongil Lee, Jakob Troidl, Forrest Collman, Luke Bailey, Angerica Fitzmaurice, Rohin Kar, Benjamin Field, Hank Wu, Julian Wagner-Carena, David Aley, Joanna Lau, Zudi Lin, Donglai Wei, Hanspeter Pfister, Adi Peleg, Viren Jain and Jeff W. Lichtman, 10 May 2024, Science. DOI: 10.1126/science.adk4858

DVDV1551RTWW78V